Replacing carmustine by thiotepa and cyclophosphamide for autologous stem cell transplantation in Hodgkin’s and non-Hodgkin’s B-cell lymphoma
Replacing carmustine by thiotepa and cyclophosphamide for autologous stem cell transplantation in Hodgkin’s and non-Hodgkin’s B-cell lymphomaBone Marrow Transplantation, Published online: 16 October 2017; doi:10.1038/bmt.2017.205
Source: Bone Marrow Transplantation - Category: Hematology Authors: E Joffe D Rosenberg U Rozovski C Perry I Kirgner S Trestman O Gur F Aviv N Sarid A Kolomansky L Gepstein Y Herishanu E Naparstek Source Type: research
More News: Bone Marrow Transplant | Hematology | Lymphoma | Stem Cell Therapy | Stem Cells | Transplants